Health
2nd study testing a COVID-19 antibody drug setback – Jamaica Star Online
(AP) – For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalised patients….
(AP) – For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalised patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients, those who need intense oxygen treatment or breathing machines, because of a potential safety problem and unfavorable balance of risks and benefits.
The study can continue to test the two-antibody…
Continue Reading